Skip to main content
. 2017 Oct 16;12(10):e0186338. doi: 10.1371/journal.pone.0186338

Table 2. Factors associated with positive anti-HAV antibody in the 2012–2016 cohort.

Anti-HAV antibody Univariate Multivariate
Negative(n = 2255) Positive(n = 605) OR 95% CI p OR 95% CI P
Age, mean ± SD, years 31.1 ± 8.0 39.3 ± 10.8 - - <0.01 1.13 1.11–1.15 <0.01
Male sex, n (%) 2171 (96.3) 559 (92.4) 0.47 0.32–0.68 <0.01 0.59 0.28–1.23 0.29
CD4, mean ± SD, cells/μl 287.1 ± 188.0 277.6 ± 199.5 - - 0.28 - - -
Plasma HIV RNA load, mean ± SD, log10 copies/ml 4.8 ± 0.8 4.7 ± 0.8 - - 0.01 0.95 0.83–1.09 0.46
Residence in Taiwan, n (%) <0.01
    Northern 1579 (70.0) 434 (71.7) Referent Referent
    Central 216 (9.6) 100 (16.5) 1.68 1.30–2.18 <0.01 0.75 0.48–1.16 0.19
    Southern 460 (20.4) 71 (11.7) 0.56 0.43–0.74 <0.01 0.49 0.34–0.72 <0.01
Risk group, n (%) <0.01
    MSM 1857 (82.3) 372 (61.5) Referent Referent
    Heterosexuals 104 (4.6) 62 (10.2) 2.94 2.35–3.68 <0.01 1.49 0.83–2.66 0.18
    IDUs 275 (12.2) 162 (26.8) 2.98 2.13–4.15 <0.01 1.44 0.75–2.75 0.27
    Others 19 (0.8) 9 (1.5) 2.37 1.06–5.27 0.03 2.861 0.76–10.85 0.12
HBV infectiona, n (%) 427/1559 (27.4) 220/371 (59.3) 3.86 3.05–4.89 <0.01 1.44 1.08–1.93 0.01
Anti-HBs-positive, n (%) 864/1652 (52.3) 219/399 (54.9) 1.11 0.89–1.38 0.35 - - -
Anti-HCV-positive, n (%) 325/2249 (14.5) 186/600 (31.0) 2.66 2.16–3.28 <0.01 1.523 0.90–2.59 0.12
RPR-positive, n (%) 404/1622 (24.9) 87/391 (22.3) 0.86 0.66–1.12 0.27 - - -

Abbreviations: 95% CI, 95% confidence interval; anti-HAV, anti-hepatitis A virus; anti-HBs, anti-hepatitis B surface; anti-HBc, anti-hepatitis B core; anti-HCV, anti-hepatitis C virus; HBsAg, hepatitis B surface antigen; IDUs, injecting drug users; MSM, men who have sex with men; OR, odds ratio; RPR, rapid plasma reagin; SD, standard deviation.

aHBV infection indicates presence of either HBsAg, anti-HBc or both.